(Reuters) -Denmark's Novo Nordisk is partnering with biotech company Deep Apple Therapeutics in a deal worth up to $812 million to develop drugs for cardiometabolic diseases, including obesity, the ...
Stock photo from Getty Images. The Ohio Board of Pharmacy on Tuesday suspended the license of a beauty spa after determining that it was giving patients dangerous drugs that lacked the proper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results